Draegerwerk Ag & Co. Kgaa · XETR:DRW8

Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — 9M 2024 Earnings Presentation

15 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Oct 29, 2024

  1. Slide 1: 9M Conference Call

    9M Conference Call Drägerwerk AG & Co. KGaA October 29, 2024, Lübeck

  2. Slide 2: Disclaimer

    Disclaimer — This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future

  3. Slide 3: Agenda

    Agenda — 01 Dräger Business Highlights 02 Financials 9M 2024 03 Outlook FY 2024 Drägerwerk AG & Co. KGaA 3

  4. Slide 4: Dräger Business Highlights

    01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4

  5. Slide 5: 9M 2024 Highlights

    9M 2024 Paving the way to Stable net sales – earnings our annual targets and cash flow improved Highlights Continued good demand: order intake above the high level of the prior-year period Robust sales development: Net sales EBIT net sales almost reaching the high level of the prior-year period EUR

  6. Slide 6: Financials 9M 2024

    02 Financials 9M 2024 Drägerwerk AG & Co. KGaA 6

  7. Slide 7: Business development Group

    Business development Group Order entry 9M 2023 9M 2024 Change — (€ million) (fx-adj.) Germany 546.8 586.7 +7.3 Net sales (€ million) EMEA 906.7 923.6 +1.8 -0.7% -0.4% Americas 517.2 521.8 +2.3 fx-adj fx-adj -1.8% -1.1% APAC 432.6 388.5 -7.7 nominal nominal 2,321 2,295 Total 2,403.3 2,420.5 +1.4 789

  8. Slide 8: Business development Medical

    Business development Medical Order entry 9M 2023 9M 2024 Change — (€ million) (fx-adj.) Germany 305.3 304.9 -0.1 Net sales (€ million) EMEA 481.2 472.2 -2.0 -0.8% -4.6% Americas 342.6 352.2 +4.2 fx-adj fx-adj -2.1% -5.4% APAC 281.6 239.2 -12.3 nominal nominal 1.359 Total 1,410.7 1,368.5 -2.1 1.285 4

  9. Slide 9: Business development Safety

    Business development Safety Order entry 9M 2023 9M 2024 Change — (€ million) (fx-adj.) Germany 241.6 281.8 +16.7 Net sales (€ million) EMEA 425.5 451.4 +6.0 -0.6% +5.5% Americas 174.6 169.6 -1.4 fx-adj fx-adj -1.3% +5.0% APAC 151.0 149.3 +0.9 nominal nominal 1.010 Total 992.7 1,052.1 +6.5 962 340 33

  10. Slide 10: Key figures

    Key figures 9M 2024 9M 2023 Change € million € million % Cashflow (from operating activities) 57.2 46.8 +22.4 Investments 78.9 95.9 -17.7 Cash and cash equivalents1 179.8 181.3 -0.8 Net financial debt1 229.0 301.7 -24.1 Net financial debt1 / EBITDA2 0.7 1.1 Capital employed 1 1,550.7 1,619.9 -4.3 RO

  11. Slide 11: Outlook FY 2024

    03 Outlook FY 2024 Drägerwerk AG & Co. KGaA 11

  12. Slide 12: Outlook

    Outlook Results achieved Forecast for Current forecast for for fiscal year 2023 fiscal year 2024 fiscal year 2024 Net sales (net of currency effects) 13.1% 1.0 to 5.0% lower half of range Gross margin 43.3% 43.0 to 45.0% confirmed EBIT margin 4.9% 2.5 to 5.5% upper half of range Dräger Value Added (

  13. Slide 13: Questions & Answers

    Questions & Answers Drägerwerk AG & Co. KGaA 13

  14. Slide 14: Financial calendar

    Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. April 3, 2025 Annual Report 2024 Conference call April 30, 2025 Report for the first three months 2025 Conference c

  15. Slide 15: Thank you

    Thank you Thomas Fischler Nikolaus Hammerschmidt Head of Treasury & Investor Relations Investor Relations Manager Moislinger Alle 53-55 Moislinger Alle 53-55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel. +49 451 882 2685 Tel. +49 451 882 8903 Mail: thomas.fischler@draeger.com Mail: nikolaus.hamme

Drägerwerk AG & Co. KGaA — 9M 2024 Earnings Presentation on 6ix